Zomedica Stock Is At Serious Risk Unless Bulls Commit

InvestorPlace2021-05-20

ZOM stock is too wild for its own good and potential investors should note the risk Investing is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

GoodLife99
2021-06-04
GoodLife99
Looking back the history, it's took a journey to reach this price, no harm to built small warehouse as when it surge, it's beyond imagination, yet good sharing.[微笑]
chiew
2021-05-27
chiew
Whebdly?
HappyTrade
2021-05-22
HappyTrade
Waiting for recovery[捂臉]
Kingvect
2021-05-20
Kingvect
Yes
BigMac8885
2021-05-20
BigMac8885
Pls like and comment
- Huathk:
  Gd
RinaL
2021-05-20
RinaL
Cash flow looks ok

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1114328605?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-05-20 17:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1114328605","market":"us","top_or_hot":-1,"title":"Zomedica Stock Is At Serious Risk Unless Bulls Commit","media":"InvestorPlace","content":"<div>\n<p>ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often ...</p>\n\n<a href=\"https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zomedica Stock Is At Serious Risk Unless Bulls Commit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZomedica Stock Is At Serious Risk Unless Bulls Commit\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 17:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often ...</p>\n\n<a href=\"https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ZOM","symbol_name":"Zomedica Pharmaceuticals Corp.","start_time":0,"source_url":"https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/","article_id":"1114328605","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1114328605","pubTimestamp":1621502610,"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"ZOM":"Zomedica Pharmaceuticals Corp."},"translate_title":"除非多头出手，否则Zomedica股票面临严重风险","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZOM":0.9},"content_text":"ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often from avoidable scenarios.Zomedica (NYSEAMERICAN:ZOM) stock is a magnet for hopeful investors and its low-dollar ticket price is the lure.\nThe current trend on Wall Street is to chase home-run monstrous spikes. Hopefuls feel they have good reason to believe that is how things work. This mantra used to be more confined to penny stocks, but now it happens everywhere.\nThe bands on social media have succeeded in creating vortexes that launch prices into the stratosphere. Most famous were the shenanigans with GameStop (NYSE:GME) and AMCEntertainment (NYSE:AMC). In fact, AMC stock rallied 40% in 24 hours just last week.\nZOM Stock and Risk\nZOM stock trades fast because at around 80 cents per share it seems harmless. It’s easy to forget that it can still cause us to lose 100% of our investment.\nUnder normal circumstance, when I invest in a ticker I have the company fundamentals for support. On bad days, the metrics can attract buyers to help ease the selling. With ZOM those are virtually missing so the drops happen in free fall format.\nIn early April,I wrote about downside risk. The stock is now 40% cheaper, my suggestion for investors is to continue to avoid it.\nIn hindsight, my message a month ago was on point and nothing has changed. Management had the opportunity to change opinions with their earnings report last week. But investors shrugged it off with a tepid reaction at best. My comments are not to demean their efforts because they are trying hard.\nWall Street Does Not Like Change\nRecently management announced a shift in distribution strategies. Their goal is migrate TruForma to direct sales. The company CEO suggested this will take two years to accomplish, so it’s a let-down reaction in the stock. What matters for price are market expectations and what they think of the developments. Wall Street doesn’t like change because it comes with a lot of question marks. For now, investors are skeptical about the company’s response.\nTechnically, the stock has the chance at holding recent support. But if last week’s lows fail, ZOM stock will close the gap 40% below that. Beware of chasing rallies because they are likely to fade. This is what happened late April as the stock soared 75% in under a week. Sadly, it quickly crashed and set a new low.\nClearly, the rips are opportunities for investors to salvage principal and profits. Until this behavior changes this is a potential trap, not an opportunity.\nThey say that in every bad situation there is a bit of good. This combination of high volatility and low fundamental substance are an avoidable hazard. But that is the draw for traders – and there the opportunities are aplenty. This would suit active traders who know their way around reading charts and ticker tapes.\nA Better Trade Than Investment\nSource: Charts by TradingView\nFor my conclusion today, I will reiterate my admiration of their cause. They are seeking to help people and pets so I am rooting for them. The better idea is to trade ZOM stock, not invest in it. From an investment perspective I fail to see the need for the risk. I prefer to use stocks where I have tangible justification for my enthusiasm.\nChewy (NYSE:CHWY) stock, for example, has also fallen from the sky. It is now 40% below its highs and struggling to find footing. At least with CHWY stock, investors have proof that management is succeeding. They more than tripled revenues in under four years. I can confidently expect that in the long run, the stock will heal.\nI can’t say the same for ZOM, so my bet on upside in ZOM stock would be pure hope.","kind":null,"is_publish_news":false,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":118546947,"gmtCreate":1622741712989,"gmtModify":1704190326567,"author":{"id":"3573390365123336","authorId":"3573390365123336","name":"GoodLife99","avatar":"https://static.tigerbbs.com/93bc72ed8ecc035497d64dcad3dcf3d8","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":4,"crmLevelSwitch":1,"idStr":"3573390365123336","authorIdStr":"3573390365123336"},"htmlText":"Looking back the history, it's took a journey to reach this price, no harm to built small warehouse as when it surge, it's beyond imagination, yet good sharing.[微笑]&nbsp;","listText":"Looking back the history, it's took a journey to reach this price, no harm to built small warehouse as when it surge, it's beyond imagination, yet good sharing.[微笑]&nbsp;","text":"Looking back the history, it's took a journey to reach this price, no harm to built small warehouse as when it surge, it's beyond imagination, yet good sharing.[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/118546947","repostId":1114328605,"repostType":2,"repost":{"id":"1114328605","pubTimestamp":1621502610,"share":"https://ttm.financial/m/news/1114328605?lang=&edition=fundamental","pubTime":"2021-05-20 17:23","market":"us","language":"en","title":"Zomedica Stock Is At Serious Risk Unless Bulls Commit","url":"https://stock-news.laohu8.com/highlight/detail?id=1114328605","media":"InvestorPlace","summary":"ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not","content":"<p>ZOM stock is too wild for its own good and potential investors should note the risk</p>\n<p>Investing is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often from avoidable scenarios.<b>Zomedica</b>&nbsp;(NYSEAMERICAN:<b><u>ZOM</u></b>) stock is a magnet for hopeful investors and its low-dollar ticket price is the lure.</p>\n<p>The current trend on Wall Street is to chase home-run monstrous spikes. Hopefuls feel they have good reason to believe that is how things work. This mantra used to be more confined to penny stocks, but now it happens everywhere.</p>\n<p>The bands on social media have succeeded in creating vortexes that launch prices into the stratosphere. Most famous were the shenanigans with&nbsp;<b>GameStop</b>&nbsp;(NYSE:<b><u>GME</u></b>) and&nbsp;<b>AMCEntertainment</b>&nbsp;(NYSE:<b><u>AMC</u></b>). In fact, AMC stock rallied 40% in 24 hours just last week.</p>\n<p><b>ZOM Stock and Risk</b></p>\n<p>ZOM stock trades fast because at around 80 cents per share it seems harmless. It’s easy to forget that it can still cause us to lose 100% of our investment.</p>\n<p>Under normal circumstance, when I invest in a ticker I have the company fundamentals for support. On bad days, the metrics can attract buyers to help ease the selling. With ZOM those are virtually missing so the drops happen in free fall format.</p>\n<p>In early April,I wrote about downside risk. The stock is now 40% cheaper, my suggestion for investors is to continue to avoid it.</p>\n<p>In hindsight, my message a month ago was on point and nothing has changed. Management had the opportunity to change opinions with their earnings report last week. But investors shrugged it off with a tepid reaction at best. My comments are not to demean their efforts because they are trying hard.</p>\n<p><b>Wall Street Does Not Like Change</b></p>\n<p>Recently management announced a shift in distribution strategies. Their goal is&nbsp;migrate TruForma to direct sales. The company CEO suggested this will take two years to accomplish, so it’s a let-down reaction in the stock. What matters for price are market expectations and what they think of the developments. Wall Street doesn’t like change because it comes with a lot of question marks. For now, investors are skeptical about the company’s response.</p>\n<p>Technically, the stock has the chance at holding recent support. But if last week’s lows fail, ZOM stock will close the gap 40% below that. Beware of chasing rallies because they are likely to fade. This is what happened late April as the stock soared 75% in under a week. Sadly, it quickly crashed and set a new low.</p>\n<p>Clearly, the rips are opportunities for investors to salvage principal and profits. Until this behavior changes this is a potential trap, not an opportunity.</p>\n<p>They say that in every bad situation there is a bit of good. This combination of high volatility and low fundamental substance are an avoidable hazard. But that is the draw for traders – and there the opportunities are aplenty. This would suit active traders who know their way around reading charts and ticker tapes.</p>\n<p><b>A Better Trade Than Investment</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/181971fed9d932f30c01ebc5ac7ac0fb\" tg-width=\"1533\" tg-height=\"818\"><span>Source: Charts by TradingView</span></p>\n<p>For my conclusion today, I will reiterate my admiration of their cause. They are seeking to help people and pets so I am rooting for them. The better idea is to trade ZOM stock, not invest in it. From an investment perspective I fail to see the need for the risk. I prefer to use stocks where I have tangible justification for my enthusiasm.</p>\n<p><b>Chewy</b>&nbsp;(NYSE:<b><u>CHWY</u></b>) stock, for example, has also fallen from the sky. It is now 40% below its highs and struggling to find footing. At least with CHWY stock, investors have proof that management is succeeding. They more than tripled revenues in under four years. I can confidently expect that in the long run, the stock will heal.</p>\n<p>I can’t say the same for ZOM, so my bet on upside in ZOM stock would be pure hope.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zomedica Stock Is At Serious Risk Unless Bulls Commit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZomedica Stock Is At Serious Risk Unless Bulls Commit\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 17:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often ...</p>\n\n<a href=\"https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZOM":"Zomedica Pharmaceuticals Corp."},"source_url":"https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114328605","content_text":"ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often from avoidable scenarios.Zomedica (NYSEAMERICAN:ZOM) stock is a magnet for hopeful investors and its low-dollar ticket price is the lure.\nThe current trend on Wall Street is to chase home-run monstrous spikes. Hopefuls feel they have good reason to believe that is how things work. This mantra used to be more confined to penny stocks, but now it happens everywhere.\nThe bands on social media have succeeded in creating vortexes that launch prices into the stratosphere. Most famous were the shenanigans with GameStop (NYSE:GME) and AMCEntertainment (NYSE:AMC). In fact, AMC stock rallied 40% in 24 hours just last week.\nZOM Stock and Risk\nZOM stock trades fast because at around 80 cents per share it seems harmless. It’s easy to forget that it can still cause us to lose 100% of our investment.\nUnder normal circumstance, when I invest in a ticker I have the company fundamentals for support. On bad days, the metrics can attract buyers to help ease the selling. With ZOM those are virtually missing so the drops happen in free fall format.\nIn early April,I wrote about downside risk. The stock is now 40% cheaper, my suggestion for investors is to continue to avoid it.\nIn hindsight, my message a month ago was on point and nothing has changed. Management had the opportunity to change opinions with their earnings report last week. But investors shrugged it off with a tepid reaction at best. My comments are not to demean their efforts because they are trying hard.\nWall Street Does Not Like Change\nRecently management announced a shift in distribution strategies. Their goal is migrate TruForma to direct sales. The company CEO suggested this will take two years to accomplish, so it’s a let-down reaction in the stock. What matters for price are market expectations and what they think of the developments. Wall Street doesn’t like change because it comes with a lot of question marks. For now, investors are skeptical about the company’s response.\nTechnically, the stock has the chance at holding recent support. But if last week’s lows fail, ZOM stock will close the gap 40% below that. Beware of chasing rallies because they are likely to fade. This is what happened late April as the stock soared 75% in under a week. Sadly, it quickly crashed and set a new low.\nClearly, the rips are opportunities for investors to salvage principal and profits. Until this behavior changes this is a potential trap, not an opportunity.\nThey say that in every bad situation there is a bit of good. This combination of high volatility and low fundamental substance are an avoidable hazard. But that is the draw for traders – and there the opportunities are aplenty. This would suit active traders who know their way around reading charts and ticker tapes.\nA Better Trade Than Investment\nSource: Charts by TradingView\nFor my conclusion today, I will reiterate my admiration of their cause. They are seeking to help people and pets so I am rooting for them. The better idea is to trade ZOM stock, not invest in it. From an investment perspective I fail to see the need for the risk. I prefer to use stocks where I have tangible justification for my enthusiasm.\nChewy (NYSE:CHWY) stock, for example, has also fallen from the sky. It is now 40% below its highs and struggling to find footing. At least with CHWY stock, investors have proof that management is succeeding. They more than tripled revenues in under four years. I can confidently expect that in the long run, the stock will heal.\nI can’t say the same for ZOM, so my bet on upside in ZOM stock would be pure hope.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":135984919,"gmtCreate":1622126269131,"gmtModify":1704179993898,"author":{"id":"3566850909705069","authorId":"3566850909705069","name":"chiew","avatar":"https://static.tigerbbs.com/6a955817d8518ffedcf0489868ef4a98","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":2,"crmLevelSwitch":0,"idStr":"3566850909705069","authorIdStr":"3566850909705069"},"htmlText":"Whebdly?","listText":"Whebdly?","text":"Whebdly?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/135984919","repostId":1114328605,"repostType":2,"repost":{"id":"1114328605","pubTimestamp":1621502610,"share":"https://ttm.financial/m/news/1114328605?lang=&edition=fundamental","pubTime":"2021-05-20 17:23","market":"us","language":"en","title":"Zomedica Stock Is At Serious Risk Unless Bulls Commit","url":"https://stock-news.laohu8.com/highlight/detail?id=1114328605","media":"InvestorPlace","summary":"ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not","content":"<p>ZOM stock is too wild for its own good and potential investors should note the risk</p>\n<p>Investing is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often from avoidable scenarios.<b>Zomedica</b>&nbsp;(NYSEAMERICAN:<b><u>ZOM</u></b>) stock is a magnet for hopeful investors and its low-dollar ticket price is the lure.</p>\n<p>The current trend on Wall Street is to chase home-run monstrous spikes. Hopefuls feel they have good reason to believe that is how things work. This mantra used to be more confined to penny stocks, but now it happens everywhere.</p>\n<p>The bands on social media have succeeded in creating vortexes that launch prices into the stratosphere. Most famous were the shenanigans with&nbsp;<b>GameStop</b>&nbsp;(NYSE:<b><u>GME</u></b>) and&nbsp;<b>AMCEntertainment</b>&nbsp;(NYSE:<b><u>AMC</u></b>). In fact, AMC stock rallied 40% in 24 hours just last week.</p>\n<p><b>ZOM Stock and Risk</b></p>\n<p>ZOM stock trades fast because at around 80 cents per share it seems harmless. It’s easy to forget that it can still cause us to lose 100% of our investment.</p>\n<p>Under normal circumstance, when I invest in a ticker I have the company fundamentals for support. On bad days, the metrics can attract buyers to help ease the selling. With ZOM those are virtually missing so the drops happen in free fall format.</p>\n<p>In early April,I wrote about downside risk. The stock is now 40% cheaper, my suggestion for investors is to continue to avoid it.</p>\n<p>In hindsight, my message a month ago was on point and nothing has changed. Management had the opportunity to change opinions with their earnings report last week. But investors shrugged it off with a tepid reaction at best. My comments are not to demean their efforts because they are trying hard.</p>\n<p><b>Wall Street Does Not Like Change</b></p>\n<p>Recently management announced a shift in distribution strategies. Their goal is&nbsp;migrate TruForma to direct sales. The company CEO suggested this will take two years to accomplish, so it’s a let-down reaction in the stock. What matters for price are market expectations and what they think of the developments. Wall Street doesn’t like change because it comes with a lot of question marks. For now, investors are skeptical about the company’s response.</p>\n<p>Technically, the stock has the chance at holding recent support. But if last week’s lows fail, ZOM stock will close the gap 40% below that. Beware of chasing rallies because they are likely to fade. This is what happened late April as the stock soared 75% in under a week. Sadly, it quickly crashed and set a new low.</p>\n<p>Clearly, the rips are opportunities for investors to salvage principal and profits. Until this behavior changes this is a potential trap, not an opportunity.</p>\n<p>They say that in every bad situation there is a bit of good. This combination of high volatility and low fundamental substance are an avoidable hazard. But that is the draw for traders – and there the opportunities are aplenty. This would suit active traders who know their way around reading charts and ticker tapes.</p>\n<p><b>A Better Trade Than Investment</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/181971fed9d932f30c01ebc5ac7ac0fb\" tg-width=\"1533\" tg-height=\"818\"><span>Source: Charts by TradingView</span></p>\n<p>For my conclusion today, I will reiterate my admiration of their cause. They are seeking to help people and pets so I am rooting for them. The better idea is to trade ZOM stock, not invest in it. From an investment perspective I fail to see the need for the risk. I prefer to use stocks where I have tangible justification for my enthusiasm.</p>\n<p><b>Chewy</b>&nbsp;(NYSE:<b><u>CHWY</u></b>) stock, for example, has also fallen from the sky. It is now 40% below its highs and struggling to find footing. At least with CHWY stock, investors have proof that management is succeeding. They more than tripled revenues in under four years. I can confidently expect that in the long run, the stock will heal.</p>\n<p>I can’t say the same for ZOM, so my bet on upside in ZOM stock would be pure hope.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zomedica Stock Is At Serious Risk Unless Bulls Commit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZomedica Stock Is At Serious Risk Unless Bulls Commit\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 17:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often ...</p>\n\n<a href=\"https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZOM":"Zomedica Pharmaceuticals Corp."},"source_url":"https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114328605","content_text":"ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often from avoidable scenarios.Zomedica (NYSEAMERICAN:ZOM) stock is a magnet for hopeful investors and its low-dollar ticket price is the lure.\nThe current trend on Wall Street is to chase home-run monstrous spikes. Hopefuls feel they have good reason to believe that is how things work. This mantra used to be more confined to penny stocks, but now it happens everywhere.\nThe bands on social media have succeeded in creating vortexes that launch prices into the stratosphere. Most famous were the shenanigans with GameStop (NYSE:GME) and AMCEntertainment (NYSE:AMC). In fact, AMC stock rallied 40% in 24 hours just last week.\nZOM Stock and Risk\nZOM stock trades fast because at around 80 cents per share it seems harmless. It’s easy to forget that it can still cause us to lose 100% of our investment.\nUnder normal circumstance, when I invest in a ticker I have the company fundamentals for support. On bad days, the metrics can attract buyers to help ease the selling. With ZOM those are virtually missing so the drops happen in free fall format.\nIn early April,I wrote about downside risk. The stock is now 40% cheaper, my suggestion for investors is to continue to avoid it.\nIn hindsight, my message a month ago was on point and nothing has changed. Management had the opportunity to change opinions with their earnings report last week. But investors shrugged it off with a tepid reaction at best. My comments are not to demean their efforts because they are trying hard.\nWall Street Does Not Like Change\nRecently management announced a shift in distribution strategies. Their goal is migrate TruForma to direct sales. The company CEO suggested this will take two years to accomplish, so it’s a let-down reaction in the stock. What matters for price are market expectations and what they think of the developments. Wall Street doesn’t like change because it comes with a lot of question marks. For now, investors are skeptical about the company’s response.\nTechnically, the stock has the chance at holding recent support. But if last week’s lows fail, ZOM stock will close the gap 40% below that. Beware of chasing rallies because they are likely to fade. This is what happened late April as the stock soared 75% in under a week. Sadly, it quickly crashed and set a new low.\nClearly, the rips are opportunities for investors to salvage principal and profits. Until this behavior changes this is a potential trap, not an opportunity.\nThey say that in every bad situation there is a bit of good. This combination of high volatility and low fundamental substance are an avoidable hazard. But that is the draw for traders – and there the opportunities are aplenty. This would suit active traders who know their way around reading charts and ticker tapes.\nA Better Trade Than Investment\nSource: Charts by TradingView\nFor my conclusion today, I will reiterate my admiration of their cause. They are seeking to help people and pets so I am rooting for them. The better idea is to trade ZOM stock, not invest in it. From an investment perspective I fail to see the need for the risk. I prefer to use stocks where I have tangible justification for my enthusiasm.\nChewy (NYSE:CHWY) stock, for example, has also fallen from the sky. It is now 40% below its highs and struggling to find footing. At least with CHWY stock, investors have proof that management is succeeding. They more than tripled revenues in under four years. I can confidently expect that in the long run, the stock will heal.\nI can’t say the same for ZOM, so my bet on upside in ZOM stock would be pure hope.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":139463502,"gmtCreate":1621650662206,"gmtModify":1704361041970,"author":{"id":"3561676944889444","authorId":"3561676944889444","name":"HappyTrade","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3561676944889444","authorIdStr":"3561676944889444"},"htmlText":"Waiting for recovery[捂臉]&nbsp;","listText":"Waiting for recovery[捂臉]&nbsp;","text":"Waiting for recovery[捂臉]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/139463502","repostId":1114328605,"repostType":2,"repost":{"id":"1114328605","pubTimestamp":1621502610,"share":"https://ttm.financial/m/news/1114328605?lang=&edition=fundamental","pubTime":"2021-05-20 17:23","market":"us","language":"en","title":"Zomedica Stock Is At Serious Risk Unless Bulls Commit","url":"https://stock-news.laohu8.com/highlight/detail?id=1114328605","media":"InvestorPlace","summary":"ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not","content":"<p>ZOM stock is too wild for its own good and potential investors should note the risk</p>\n<p>Investing is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often from avoidable scenarios.<b>Zomedica</b>&nbsp;(NYSEAMERICAN:<b><u>ZOM</u></b>) stock is a magnet for hopeful investors and its low-dollar ticket price is the lure.</p>\n<p>The current trend on Wall Street is to chase home-run monstrous spikes. Hopefuls feel they have good reason to believe that is how things work. This mantra used to be more confined to penny stocks, but now it happens everywhere.</p>\n<p>The bands on social media have succeeded in creating vortexes that launch prices into the stratosphere. Most famous were the shenanigans with&nbsp;<b>GameStop</b>&nbsp;(NYSE:<b><u>GME</u></b>) and&nbsp;<b>AMCEntertainment</b>&nbsp;(NYSE:<b><u>AMC</u></b>). In fact, AMC stock rallied 40% in 24 hours just last week.</p>\n<p><b>ZOM Stock and Risk</b></p>\n<p>ZOM stock trades fast because at around 80 cents per share it seems harmless. It’s easy to forget that it can still cause us to lose 100% of our investment.</p>\n<p>Under normal circumstance, when I invest in a ticker I have the company fundamentals for support. On bad days, the metrics can attract buyers to help ease the selling. With ZOM those are virtually missing so the drops happen in free fall format.</p>\n<p>In early April,I wrote about downside risk. The stock is now 40% cheaper, my suggestion for investors is to continue to avoid it.</p>\n<p>In hindsight, my message a month ago was on point and nothing has changed. Management had the opportunity to change opinions with their earnings report last week. But investors shrugged it off with a tepid reaction at best. My comments are not to demean their efforts because they are trying hard.</p>\n<p><b>Wall Street Does Not Like Change</b></p>\n<p>Recently management announced a shift in distribution strategies. Their goal is&nbsp;migrate TruForma to direct sales. The company CEO suggested this will take two years to accomplish, so it’s a let-down reaction in the stock. What matters for price are market expectations and what they think of the developments. Wall Street doesn’t like change because it comes with a lot of question marks. For now, investors are skeptical about the company’s response.</p>\n<p>Technically, the stock has the chance at holding recent support. But if last week’s lows fail, ZOM stock will close the gap 40% below that. Beware of chasing rallies because they are likely to fade. This is what happened late April as the stock soared 75% in under a week. Sadly, it quickly crashed and set a new low.</p>\n<p>Clearly, the rips are opportunities for investors to salvage principal and profits. Until this behavior changes this is a potential trap, not an opportunity.</p>\n<p>They say that in every bad situation there is a bit of good. This combination of high volatility and low fundamental substance are an avoidable hazard. But that is the draw for traders – and there the opportunities are aplenty. This would suit active traders who know their way around reading charts and ticker tapes.</p>\n<p><b>A Better Trade Than Investment</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/181971fed9d932f30c01ebc5ac7ac0fb\" tg-width=\"1533\" tg-height=\"818\"><span>Source: Charts by TradingView</span></p>\n<p>For my conclusion today, I will reiterate my admiration of their cause. They are seeking to help people and pets so I am rooting for them. The better idea is to trade ZOM stock, not invest in it. From an investment perspective I fail to see the need for the risk. I prefer to use stocks where I have tangible justification for my enthusiasm.</p>\n<p><b>Chewy</b>&nbsp;(NYSE:<b><u>CHWY</u></b>) stock, for example, has also fallen from the sky. It is now 40% below its highs and struggling to find footing. At least with CHWY stock, investors have proof that management is succeeding. They more than tripled revenues in under four years. I can confidently expect that in the long run, the stock will heal.</p>\n<p>I can’t say the same for ZOM, so my bet on upside in ZOM stock would be pure hope.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zomedica Stock Is At Serious Risk Unless Bulls Commit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZomedica Stock Is At Serious Risk Unless Bulls Commit\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 17:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often ...</p>\n\n<a href=\"https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZOM":"Zomedica Pharmaceuticals Corp."},"source_url":"https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114328605","content_text":"ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often from avoidable scenarios.Zomedica (NYSEAMERICAN:ZOM) stock is a magnet for hopeful investors and its low-dollar ticket price is the lure.\nThe current trend on Wall Street is to chase home-run monstrous spikes. Hopefuls feel they have good reason to believe that is how things work. This mantra used to be more confined to penny stocks, but now it happens everywhere.\nThe bands on social media have succeeded in creating vortexes that launch prices into the stratosphere. Most famous were the shenanigans with GameStop (NYSE:GME) and AMCEntertainment (NYSE:AMC). In fact, AMC stock rallied 40% in 24 hours just last week.\nZOM Stock and Risk\nZOM stock trades fast because at around 80 cents per share it seems harmless. It’s easy to forget that it can still cause us to lose 100% of our investment.\nUnder normal circumstance, when I invest in a ticker I have the company fundamentals for support. On bad days, the metrics can attract buyers to help ease the selling. With ZOM those are virtually missing so the drops happen in free fall format.\nIn early April,I wrote about downside risk. The stock is now 40% cheaper, my suggestion for investors is to continue to avoid it.\nIn hindsight, my message a month ago was on point and nothing has changed. Management had the opportunity to change opinions with their earnings report last week. But investors shrugged it off with a tepid reaction at best. My comments are not to demean their efforts because they are trying hard.\nWall Street Does Not Like Change\nRecently management announced a shift in distribution strategies. Their goal is migrate TruForma to direct sales. The company CEO suggested this will take two years to accomplish, so it’s a let-down reaction in the stock. What matters for price are market expectations and what they think of the developments. Wall Street doesn’t like change because it comes with a lot of question marks. For now, investors are skeptical about the company’s response.\nTechnically, the stock has the chance at holding recent support. But if last week’s lows fail, ZOM stock will close the gap 40% below that. Beware of chasing rallies because they are likely to fade. This is what happened late April as the stock soared 75% in under a week. Sadly, it quickly crashed and set a new low.\nClearly, the rips are opportunities for investors to salvage principal and profits. Until this behavior changes this is a potential trap, not an opportunity.\nThey say that in every bad situation there is a bit of good. This combination of high volatility and low fundamental substance are an avoidable hazard. But that is the draw for traders – and there the opportunities are aplenty. This would suit active traders who know their way around reading charts and ticker tapes.\nA Better Trade Than Investment\nSource: Charts by TradingView\nFor my conclusion today, I will reiterate my admiration of their cause. They are seeking to help people and pets so I am rooting for them. The better idea is to trade ZOM stock, not invest in it. From an investment perspective I fail to see the need for the risk. I prefer to use stocks where I have tangible justification for my enthusiasm.\nChewy (NYSE:CHWY) stock, for example, has also fallen from the sky. It is now 40% below its highs and struggling to find footing. At least with CHWY stock, investors have proof that management is succeeding. They more than tripled revenues in under four years. I can confidently expect that in the long run, the stock will heal.\nI can’t say the same for ZOM, so my bet on upside in ZOM stock would be pure hope.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":130945155,"gmtCreate":1621508350877,"gmtModify":1704358753757,"author":{"id":"3571149964024608","authorId":"3571149964024608","name":"Kingvect","avatar":"https://static.tigerbbs.com/da838815e20279e45c29d95e07bdb79a","vip":1,"crmLevel":4,"crmLevelSwitch":1,"idStr":"3571149964024608","authorIdStr":"3571149964024608"},"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/130945155","repostId":1114328605,"repostType":4,"repost":{"id":"1114328605","pubTimestamp":1621502610,"share":"https://ttm.financial/m/news/1114328605?lang=&edition=fundamental","pubTime":"2021-05-20 17:23","market":"us","language":"en","title":"Zomedica Stock Is At Serious Risk Unless Bulls Commit","url":"https://stock-news.laohu8.com/highlight/detail?id=1114328605","media":"InvestorPlace","summary":"ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not","content":"<p>ZOM stock is too wild for its own good and potential investors should note the risk</p>\n<p>Investing is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often from avoidable scenarios.<b>Zomedica</b>&nbsp;(NYSEAMERICAN:<b><u>ZOM</u></b>) stock is a magnet for hopeful investors and its low-dollar ticket price is the lure.</p>\n<p>The current trend on Wall Street is to chase home-run monstrous spikes. Hopefuls feel they have good reason to believe that is how things work. This mantra used to be more confined to penny stocks, but now it happens everywhere.</p>\n<p>The bands on social media have succeeded in creating vortexes that launch prices into the stratosphere. Most famous were the shenanigans with&nbsp;<b>GameStop</b>&nbsp;(NYSE:<b><u>GME</u></b>) and&nbsp;<b>AMCEntertainment</b>&nbsp;(NYSE:<b><u>AMC</u></b>). In fact, AMC stock rallied 40% in 24 hours just last week.</p>\n<p><b>ZOM Stock and Risk</b></p>\n<p>ZOM stock trades fast because at around 80 cents per share it seems harmless. It’s easy to forget that it can still cause us to lose 100% of our investment.</p>\n<p>Under normal circumstance, when I invest in a ticker I have the company fundamentals for support. On bad days, the metrics can attract buyers to help ease the selling. With ZOM those are virtually missing so the drops happen in free fall format.</p>\n<p>In early April,I wrote about downside risk. The stock is now 40% cheaper, my suggestion for investors is to continue to avoid it.</p>\n<p>In hindsight, my message a month ago was on point and nothing has changed. Management had the opportunity to change opinions with their earnings report last week. But investors shrugged it off with a tepid reaction at best. My comments are not to demean their efforts because they are trying hard.</p>\n<p><b>Wall Street Does Not Like Change</b></p>\n<p>Recently management announced a shift in distribution strategies. Their goal is&nbsp;migrate TruForma to direct sales. The company CEO suggested this will take two years to accomplish, so it’s a let-down reaction in the stock. What matters for price are market expectations and what they think of the developments. Wall Street doesn’t like change because it comes with a lot of question marks. For now, investors are skeptical about the company’s response.</p>\n<p>Technically, the stock has the chance at holding recent support. But if last week’s lows fail, ZOM stock will close the gap 40% below that. Beware of chasing rallies because they are likely to fade. This is what happened late April as the stock soared 75% in under a week. Sadly, it quickly crashed and set a new low.</p>\n<p>Clearly, the rips are opportunities for investors to salvage principal and profits. Until this behavior changes this is a potential trap, not an opportunity.</p>\n<p>They say that in every bad situation there is a bit of good. This combination of high volatility and low fundamental substance are an avoidable hazard. But that is the draw for traders – and there the opportunities are aplenty. This would suit active traders who know their way around reading charts and ticker tapes.</p>\n<p><b>A Better Trade Than Investment</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/181971fed9d932f30c01ebc5ac7ac0fb\" tg-width=\"1533\" tg-height=\"818\"><span>Source: Charts by TradingView</span></p>\n<p>For my conclusion today, I will reiterate my admiration of their cause. They are seeking to help people and pets so I am rooting for them. The better idea is to trade ZOM stock, not invest in it. From an investment perspective I fail to see the need for the risk. I prefer to use stocks where I have tangible justification for my enthusiasm.</p>\n<p><b>Chewy</b>&nbsp;(NYSE:<b><u>CHWY</u></b>) stock, for example, has also fallen from the sky. It is now 40% below its highs and struggling to find footing. At least with CHWY stock, investors have proof that management is succeeding. They more than tripled revenues in under four years. I can confidently expect that in the long run, the stock will heal.</p>\n<p>I can’t say the same for ZOM, so my bet on upside in ZOM stock would be pure hope.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zomedica Stock Is At Serious Risk Unless Bulls Commit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZomedica Stock Is At Serious Risk Unless Bulls Commit\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 17:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often ...</p>\n\n<a href=\"https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZOM":"Zomedica Pharmaceuticals Corp."},"source_url":"https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114328605","content_text":"ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often from avoidable scenarios.Zomedica (NYSEAMERICAN:ZOM) stock is a magnet for hopeful investors and its low-dollar ticket price is the lure.\nThe current trend on Wall Street is to chase home-run monstrous spikes. Hopefuls feel they have good reason to believe that is how things work. This mantra used to be more confined to penny stocks, but now it happens everywhere.\nThe bands on social media have succeeded in creating vortexes that launch prices into the stratosphere. Most famous were the shenanigans with GameStop (NYSE:GME) and AMCEntertainment (NYSE:AMC). In fact, AMC stock rallied 40% in 24 hours just last week.\nZOM Stock and Risk\nZOM stock trades fast because at around 80 cents per share it seems harmless. It’s easy to forget that it can still cause us to lose 100% of our investment.\nUnder normal circumstance, when I invest in a ticker I have the company fundamentals for support. On bad days, the metrics can attract buyers to help ease the selling. With ZOM those are virtually missing so the drops happen in free fall format.\nIn early April,I wrote about downside risk. The stock is now 40% cheaper, my suggestion for investors is to continue to avoid it.\nIn hindsight, my message a month ago was on point and nothing has changed. Management had the opportunity to change opinions with their earnings report last week. But investors shrugged it off with a tepid reaction at best. My comments are not to demean their efforts because they are trying hard.\nWall Street Does Not Like Change\nRecently management announced a shift in distribution strategies. Their goal is migrate TruForma to direct sales. The company CEO suggested this will take two years to accomplish, so it’s a let-down reaction in the stock. What matters for price are market expectations and what they think of the developments. Wall Street doesn’t like change because it comes with a lot of question marks. For now, investors are skeptical about the company’s response.\nTechnically, the stock has the chance at holding recent support. But if last week’s lows fail, ZOM stock will close the gap 40% below that. Beware of chasing rallies because they are likely to fade. This is what happened late April as the stock soared 75% in under a week. Sadly, it quickly crashed and set a new low.\nClearly, the rips are opportunities for investors to salvage principal and profits. Until this behavior changes this is a potential trap, not an opportunity.\nThey say that in every bad situation there is a bit of good. This combination of high volatility and low fundamental substance are an avoidable hazard. But that is the draw for traders – and there the opportunities are aplenty. This would suit active traders who know their way around reading charts and ticker tapes.\nA Better Trade Than Investment\nSource: Charts by TradingView\nFor my conclusion today, I will reiterate my admiration of their cause. They are seeking to help people and pets so I am rooting for them. The better idea is to trade ZOM stock, not invest in it. From an investment perspective I fail to see the need for the risk. I prefer to use stocks where I have tangible justification for my enthusiasm.\nChewy (NYSE:CHWY) stock, for example, has also fallen from the sky. It is now 40% below its highs and struggling to find footing. At least with CHWY stock, investors have proof that management is succeeding. They more than tripled revenues in under four years. I can confidently expect that in the long run, the stock will heal.\nI can’t say the same for ZOM, so my bet on upside in ZOM stock would be pure hope.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":130940577,"gmtCreate":1621507540899,"gmtModify":1704358744576,"author":{"id":"3579506230138289","authorId":"3579506230138289","name":"BigMac8885","avatar":"https://static.tigerbbs.com/e583c75322dd4651672938ebba8683b7","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3579506230138289","authorIdStr":"3579506230138289"},"htmlText":"Pls like and comment&nbsp;","listText":"Pls like and comment&nbsp;","text":"Pls like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/130940577","repostId":1114328605,"repostType":4,"repost":{"id":"1114328605","pubTimestamp":1621502610,"share":"https://ttm.financial/m/news/1114328605?lang=&edition=fundamental","pubTime":"2021-05-20 17:23","market":"us","language":"en","title":"Zomedica Stock Is At Serious Risk Unless Bulls Commit","url":"https://stock-news.laohu8.com/highlight/detail?id=1114328605","media":"InvestorPlace","summary":"ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not","content":"<p>ZOM stock is too wild for its own good and potential investors should note the risk</p>\n<p>Investing is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often from avoidable scenarios.<b>Zomedica</b>&nbsp;(NYSEAMERICAN:<b><u>ZOM</u></b>) stock is a magnet for hopeful investors and its low-dollar ticket price is the lure.</p>\n<p>The current trend on Wall Street is to chase home-run monstrous spikes. Hopefuls feel they have good reason to believe that is how things work. This mantra used to be more confined to penny stocks, but now it happens everywhere.</p>\n<p>The bands on social media have succeeded in creating vortexes that launch prices into the stratosphere. Most famous were the shenanigans with&nbsp;<b>GameStop</b>&nbsp;(NYSE:<b><u>GME</u></b>) and&nbsp;<b>AMCEntertainment</b>&nbsp;(NYSE:<b><u>AMC</u></b>). In fact, AMC stock rallied 40% in 24 hours just last week.</p>\n<p><b>ZOM Stock and Risk</b></p>\n<p>ZOM stock trades fast because at around 80 cents per share it seems harmless. It’s easy to forget that it can still cause us to lose 100% of our investment.</p>\n<p>Under normal circumstance, when I invest in a ticker I have the company fundamentals for support. On bad days, the metrics can attract buyers to help ease the selling. With ZOM those are virtually missing so the drops happen in free fall format.</p>\n<p>In early April,I wrote about downside risk. The stock is now 40% cheaper, my suggestion for investors is to continue to avoid it.</p>\n<p>In hindsight, my message a month ago was on point and nothing has changed. Management had the opportunity to change opinions with their earnings report last week. But investors shrugged it off with a tepid reaction at best. My comments are not to demean their efforts because they are trying hard.</p>\n<p><b>Wall Street Does Not Like Change</b></p>\n<p>Recently management announced a shift in distribution strategies. Their goal is&nbsp;migrate TruForma to direct sales. The company CEO suggested this will take two years to accomplish, so it’s a let-down reaction in the stock. What matters for price are market expectations and what they think of the developments. Wall Street doesn’t like change because it comes with a lot of question marks. For now, investors are skeptical about the company’s response.</p>\n<p>Technically, the stock has the chance at holding recent support. But if last week’s lows fail, ZOM stock will close the gap 40% below that. Beware of chasing rallies because they are likely to fade. This is what happened late April as the stock soared 75% in under a week. Sadly, it quickly crashed and set a new low.</p>\n<p>Clearly, the rips are opportunities for investors to salvage principal and profits. Until this behavior changes this is a potential trap, not an opportunity.</p>\n<p>They say that in every bad situation there is a bit of good. This combination of high volatility and low fundamental substance are an avoidable hazard. But that is the draw for traders – and there the opportunities are aplenty. This would suit active traders who know their way around reading charts and ticker tapes.</p>\n<p><b>A Better Trade Than Investment</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/181971fed9d932f30c01ebc5ac7ac0fb\" tg-width=\"1533\" tg-height=\"818\"><span>Source: Charts by TradingView</span></p>\n<p>For my conclusion today, I will reiterate my admiration of their cause. They are seeking to help people and pets so I am rooting for them. The better idea is to trade ZOM stock, not invest in it. From an investment perspective I fail to see the need for the risk. I prefer to use stocks where I have tangible justification for my enthusiasm.</p>\n<p><b>Chewy</b>&nbsp;(NYSE:<b><u>CHWY</u></b>) stock, for example, has also fallen from the sky. It is now 40% below its highs and struggling to find footing. At least with CHWY stock, investors have proof that management is succeeding. They more than tripled revenues in under four years. I can confidently expect that in the long run, the stock will heal.</p>\n<p>I can’t say the same for ZOM, so my bet on upside in ZOM stock would be pure hope.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zomedica Stock Is At Serious Risk Unless Bulls Commit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZomedica Stock Is At Serious Risk Unless Bulls Commit\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 17:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often ...</p>\n\n<a href=\"https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZOM":"Zomedica Pharmaceuticals Corp."},"source_url":"https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114328605","content_text":"ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often from avoidable scenarios.Zomedica (NYSEAMERICAN:ZOM) stock is a magnet for hopeful investors and its low-dollar ticket price is the lure.\nThe current trend on Wall Street is to chase home-run monstrous spikes. Hopefuls feel they have good reason to believe that is how things work. This mantra used to be more confined to penny stocks, but now it happens everywhere.\nThe bands on social media have succeeded in creating vortexes that launch prices into the stratosphere. Most famous were the shenanigans with GameStop (NYSE:GME) and AMCEntertainment (NYSE:AMC). In fact, AMC stock rallied 40% in 24 hours just last week.\nZOM Stock and Risk\nZOM stock trades fast because at around 80 cents per share it seems harmless. It’s easy to forget that it can still cause us to lose 100% of our investment.\nUnder normal circumstance, when I invest in a ticker I have the company fundamentals for support. On bad days, the metrics can attract buyers to help ease the selling. With ZOM those are virtually missing so the drops happen in free fall format.\nIn early April,I wrote about downside risk. The stock is now 40% cheaper, my suggestion for investors is to continue to avoid it.\nIn hindsight, my message a month ago was on point and nothing has changed. Management had the opportunity to change opinions with their earnings report last week. But investors shrugged it off with a tepid reaction at best. My comments are not to demean their efforts because they are trying hard.\nWall Street Does Not Like Change\nRecently management announced a shift in distribution strategies. Their goal is migrate TruForma to direct sales. The company CEO suggested this will take two years to accomplish, so it’s a let-down reaction in the stock. What matters for price are market expectations and what they think of the developments. Wall Street doesn’t like change because it comes with a lot of question marks. For now, investors are skeptical about the company’s response.\nTechnically, the stock has the chance at holding recent support. But if last week’s lows fail, ZOM stock will close the gap 40% below that. Beware of chasing rallies because they are likely to fade. This is what happened late April as the stock soared 75% in under a week. Sadly, it quickly crashed and set a new low.\nClearly, the rips are opportunities for investors to salvage principal and profits. Until this behavior changes this is a potential trap, not an opportunity.\nThey say that in every bad situation there is a bit of good. This combination of high volatility and low fundamental substance are an avoidable hazard. But that is the draw for traders – and there the opportunities are aplenty. This would suit active traders who know their way around reading charts and ticker tapes.\nA Better Trade Than Investment\nSource: Charts by TradingView\nFor my conclusion today, I will reiterate my admiration of their cause. They are seeking to help people and pets so I am rooting for them. The better idea is to trade ZOM stock, not invest in it. From an investment perspective I fail to see the need for the risk. I prefer to use stocks where I have tangible justification for my enthusiasm.\nChewy (NYSE:CHWY) stock, for example, has also fallen from the sky. It is now 40% below its highs and struggling to find footing. At least with CHWY stock, investors have proof that management is succeeding. They more than tripled revenues in under four years. I can confidently expect that in the long run, the stock will heal.\nI can’t say the same for ZOM, so my bet on upside in ZOM stock would be pure hope.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4389918,"gmtCreate":1621507956609,"gmtModify":1680789899695,"authorId":3573472992263411,"author":{"id":3573472992263411,"idStr":"3573472992263411","authorId":3573472992263411,"name":"Huathk","avatar":"https://static.tigerbbs.com/43c7168c646d9ea6805194ed0003f1cc","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":130940577,"type":1,"supId":0,"prevId":0,"content":"Gd","text":"Gd","html":"Gd"}],"langContent":"EN"},{"id":130958606,"gmtCreate":1621507011905,"gmtModify":1704358736074,"author":{"id":"3580675202049961","authorId":"3580675202049961","name":"RinaL","avatar":"https://static.tigerbbs.com/4d57a0d94d1e979d5d67883d53f53ca9","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3580675202049961","authorIdStr":"3580675202049961"},"htmlText":"Cash flow looks ok","listText":"Cash flow looks ok","text":"Cash flow looks ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/130958606","repostId":1114328605,"repostType":4,"repost":{"id":"1114328605","pubTimestamp":1621502610,"share":"https://ttm.financial/m/news/1114328605?lang=&edition=fundamental","pubTime":"2021-05-20 17:23","market":"us","language":"en","title":"Zomedica Stock Is At Serious Risk Unless Bulls Commit","url":"https://stock-news.laohu8.com/highlight/detail?id=1114328605","media":"InvestorPlace","summary":"ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not","content":"<p>ZOM stock is too wild for its own good and potential investors should note the risk</p>\n<p>Investing is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often from avoidable scenarios.<b>Zomedica</b>&nbsp;(NYSEAMERICAN:<b><u>ZOM</u></b>) stock is a magnet for hopeful investors and its low-dollar ticket price is the lure.</p>\n<p>The current trend on Wall Street is to chase home-run monstrous spikes. Hopefuls feel they have good reason to believe that is how things work. This mantra used to be more confined to penny stocks, but now it happens everywhere.</p>\n<p>The bands on social media have succeeded in creating vortexes that launch prices into the stratosphere. Most famous were the shenanigans with&nbsp;<b>GameStop</b>&nbsp;(NYSE:<b><u>GME</u></b>) and&nbsp;<b>AMCEntertainment</b>&nbsp;(NYSE:<b><u>AMC</u></b>). In fact, AMC stock rallied 40% in 24 hours just last week.</p>\n<p><b>ZOM Stock and Risk</b></p>\n<p>ZOM stock trades fast because at around 80 cents per share it seems harmless. It’s easy to forget that it can still cause us to lose 100% of our investment.</p>\n<p>Under normal circumstance, when I invest in a ticker I have the company fundamentals for support. On bad days, the metrics can attract buyers to help ease the selling. With ZOM those are virtually missing so the drops happen in free fall format.</p>\n<p>In early April,I wrote about downside risk. The stock is now 40% cheaper, my suggestion for investors is to continue to avoid it.</p>\n<p>In hindsight, my message a month ago was on point and nothing has changed. Management had the opportunity to change opinions with their earnings report last week. But investors shrugged it off with a tepid reaction at best. My comments are not to demean their efforts because they are trying hard.</p>\n<p><b>Wall Street Does Not Like Change</b></p>\n<p>Recently management announced a shift in distribution strategies. Their goal is&nbsp;migrate TruForma to direct sales. The company CEO suggested this will take two years to accomplish, so it’s a let-down reaction in the stock. What matters for price are market expectations and what they think of the developments. Wall Street doesn’t like change because it comes with a lot of question marks. For now, investors are skeptical about the company’s response.</p>\n<p>Technically, the stock has the chance at holding recent support. But if last week’s lows fail, ZOM stock will close the gap 40% below that. Beware of chasing rallies because they are likely to fade. This is what happened late April as the stock soared 75% in under a week. Sadly, it quickly crashed and set a new low.</p>\n<p>Clearly, the rips are opportunities for investors to salvage principal and profits. Until this behavior changes this is a potential trap, not an opportunity.</p>\n<p>They say that in every bad situation there is a bit of good. This combination of high volatility and low fundamental substance are an avoidable hazard. But that is the draw for traders – and there the opportunities are aplenty. This would suit active traders who know their way around reading charts and ticker tapes.</p>\n<p><b>A Better Trade Than Investment</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/181971fed9d932f30c01ebc5ac7ac0fb\" tg-width=\"1533\" tg-height=\"818\"><span>Source: Charts by TradingView</span></p>\n<p>For my conclusion today, I will reiterate my admiration of their cause. They are seeking to help people and pets so I am rooting for them. The better idea is to trade ZOM stock, not invest in it. From an investment perspective I fail to see the need for the risk. I prefer to use stocks where I have tangible justification for my enthusiasm.</p>\n<p><b>Chewy</b>&nbsp;(NYSE:<b><u>CHWY</u></b>) stock, for example, has also fallen from the sky. It is now 40% below its highs and struggling to find footing. At least with CHWY stock, investors have proof that management is succeeding. They more than tripled revenues in under four years. I can confidently expect that in the long run, the stock will heal.</p>\n<p>I can’t say the same for ZOM, so my bet on upside in ZOM stock would be pure hope.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zomedica Stock Is At Serious Risk Unless Bulls Commit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZomedica Stock Is At Serious Risk Unless Bulls Commit\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-20 17:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often ...</p>\n\n<a href=\"https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZOM":"Zomedica Pharmaceuticals Corp."},"source_url":"https://investorplace.com/2021/05/zom-stock-zomedica-serious-risk-unless-bulls-commit/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114328605","content_text":"ZOM stock is too wild for its own good and potential investors should note the risk\nInvesting is not easy but it is also not hard to avoid obvious mistakes. What causes traders grief are most often from avoidable scenarios.Zomedica (NYSEAMERICAN:ZOM) stock is a magnet for hopeful investors and its low-dollar ticket price is the lure.\nThe current trend on Wall Street is to chase home-run monstrous spikes. Hopefuls feel they have good reason to believe that is how things work. This mantra used to be more confined to penny stocks, but now it happens everywhere.\nThe bands on social media have succeeded in creating vortexes that launch prices into the stratosphere. Most famous were the shenanigans with GameStop (NYSE:GME) and AMCEntertainment (NYSE:AMC). In fact, AMC stock rallied 40% in 24 hours just last week.\nZOM Stock and Risk\nZOM stock trades fast because at around 80 cents per share it seems harmless. It’s easy to forget that it can still cause us to lose 100% of our investment.\nUnder normal circumstance, when I invest in a ticker I have the company fundamentals for support. On bad days, the metrics can attract buyers to help ease the selling. With ZOM those are virtually missing so the drops happen in free fall format.\nIn early April,I wrote about downside risk. The stock is now 40% cheaper, my suggestion for investors is to continue to avoid it.\nIn hindsight, my message a month ago was on point and nothing has changed. Management had the opportunity to change opinions with their earnings report last week. But investors shrugged it off with a tepid reaction at best. My comments are not to demean their efforts because they are trying hard.\nWall Street Does Not Like Change\nRecently management announced a shift in distribution strategies. Their goal is migrate TruForma to direct sales. The company CEO suggested this will take two years to accomplish, so it’s a let-down reaction in the stock. What matters for price are market expectations and what they think of the developments. Wall Street doesn’t like change because it comes with a lot of question marks. For now, investors are skeptical about the company’s response.\nTechnically, the stock has the chance at holding recent support. But if last week’s lows fail, ZOM stock will close the gap 40% below that. Beware of chasing rallies because they are likely to fade. This is what happened late April as the stock soared 75% in under a week. Sadly, it quickly crashed and set a new low.\nClearly, the rips are opportunities for investors to salvage principal and profits. Until this behavior changes this is a potential trap, not an opportunity.\nThey say that in every bad situation there is a bit of good. This combination of high volatility and low fundamental substance are an avoidable hazard. But that is the draw for traders – and there the opportunities are aplenty. This would suit active traders who know their way around reading charts and ticker tapes.\nA Better Trade Than Investment\nSource: Charts by TradingView\nFor my conclusion today, I will reiterate my admiration of their cause. They are seeking to help people and pets so I am rooting for them. The better idea is to trade ZOM stock, not invest in it. From an investment perspective I fail to see the need for the risk. I prefer to use stocks where I have tangible justification for my enthusiasm.\nChewy (NYSE:CHWY) stock, for example, has also fallen from the sky. It is now 40% below its highs and struggling to find footing. At least with CHWY stock, investors have proof that management is succeeding. They more than tripled revenues in under four years. I can confidently expect that in the long run, the stock will heal.\nI can’t say the same for ZOM, so my bet on upside in ZOM stock would be pure hope.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":33,"commentSize":14,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1114328605"}